title: [Not Available].
authors.forename: Thomas K
authors.initials: TK
authors.lastname: Eigentler
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage; D003880:Dermatology / Q000639:trends*; D017277:Drug Approval; D005062:European Union; D019317:Evidence-Based Medicine; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D000077594:Nivolumab; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000077594:Nivolumab; C582435:pembrolizumab